Opsalon Eye Drops (Moxifloxacin Hydrochloride) (Single Use), Opsalon Eye Drops (Moxifloxacin Hydrochloride)

Adult use

1. Bacterial conjunctivitis, blepharitis, keratitis (including corneal ulcers): Typically, instill 1 drop 3 times a day. The number of instillations may be adjusted according to symptoms. 2. Aseptic treatment before and after ophthalmic surgery: Typically, instill 1 drop 5 times a day before surgery, and 1 drop 3 times a day after surgery.

This medication should only be used for direct instillation in the eye and should not be injected subconjunctivally or directly into the anterior chamber of the eye. Patients receiving systemic administration of drugs in the same class as this medication may experience severe allergic reactions, so if symptoms such as rash, difficulty breathing, or angioedema occur, administration should be stopped immediately and medical consultation should be sought. This medication should not be used in patients with hypersensitivity to this drug or in infants under one year of age. Women who are pregnant or breastfeeding should use it cautiously after consulting a doctor. During the use of this medication, side effects such as conjunctivitis, decreased vision, dry eyes, redness, pain, and itching may occur, and if these symptoms persist, medical consultation should be notified. Prolonged use may lead to the growth of resistant bacteria or infection, so it should be used only for the necessary minimum duration, and it should be discontinued if symptoms worsen. Patients wearing contact lenses should avoid wearing lenses when symptoms of bacterial conjunctivitis are present. When instilling, care should be taken to avoid contamination by not allowing the tip of the container to touch the eye or fingers, and any remaining medication after opening should be discarded after a single use. This medication should be administered at least 5 minutes apart from other eye drops, and should be stored in a cool place away from direct sunlight and out of reach of children. Safety in pregnant or nursing women has not been established, and it should only be used when the therapeutic benefits are deemed to outweigh the risks. Safety in children, especially infants less than one year old, has not been confirmed, so use should be avoided.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash accompanied by high fever, blisters, peeling skin, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy throughout the body, sudden and severe headache, lightning-like headaches, seizures, altered consciousness, visual disturbances, paralysis, urination abnormalities.

Mild side effects

Conjunctivitis, decreased vision, dry eyes, keratitis, ocular discomfort, ocular redness, ocular pain, itching, subconjunctival hemorrhage, tearing, fever, cough, infection, otitis media, pharyngitis, erythema, rhinitis, ocular pain, dysgeusia, ocular irritation, eyelid edema, blurred vision, sensory abnormalities at the application site, atrial fibrillation, dizziness, endophthalmitis, ulcerative keratitis, corneal erosion, corneal abrasion, increased intraocular pressure, corneal opacity, corneal infiltrates, corneal deposits, keratitis,

This medication should be stored in a tightly sealed container to protect it from air and moisture and should be kept at room temperature between 2 to 25 degrees Celsius. Proper storage will maintain the efficacy and safety of the medication.

Appearance

A pale yellow-green ophthalmic solution in a transparent plastic container

Package unit

[Single-use] 0.4 mL/tube x 12 units [Multi-use] 5 mL/bottle x 1 unit